Abstract:The success of cancer gene therapy highly relies on the gene delivery vector with high transfection activity and low toxicity. In the present study, eight-armed polyethylene glycol (EAP) and low molecular weight (LMW) polyethylenimine (PEI) were used as basic units to construct the architecture of a new star-shaped EAP-PEI copolymer (EAPP). MC11, a peptide capable of selectively binding fibroblast growth factor receptor (FGFR) on tumor cell membranes, was further conjugated to EAPP to produce the vector EAPP-MC11 (EAPPM) to enhance tumor targetability. This tumor-targeting vector EAPPM was observed to retard the plasmids mobility at a nitrogen/phosphorus (N/P) ratio of 3. The vector could efficiently condense plasmids within 300 nm nanoparticles with a positive zeta potential at the N/P ratio of 20 or above. While the cytotoxicity of EAPPM polyplexes was similar to that of LMW PEI, it was significantly lower than that of PEI (25 kDa) in HepG2 and PC3 cell lines. In vitro gene transfection with pDNA mediated by EAPPM showed that the transfection efficiency increased 15 times in HepG2 cells but remained at a similar level in PC3 cells in comparison with that of EAPP. By systemic injection of EAPPM/pDNA complexes into a HepG2-bearing mice model, luciferase expression detected in lung, liver, and tumor tissues demonstrated EAPPM could deliver in a targeted manner a reporter gene into tumor tissues, where the luciferase expression of EAPPM was 4 times higher than that of EAPP and even 23 times higher than that of PEI (25 kDa). Furthermore, it was found that the systemic delivery of EAPPM/pCSK-α-interferon complexes in vivo were much more effective in inhibiting tumor growth than EAPP or PEI (25 kDa). These results clearly show that EAPPM is an efficient and safe vector for FGFR-mediated targeted gene delivery both in vitro and in vivo. With low cytotoxicity and high targetability, EAPPM may have great potential as a delivery vector for future cancer gene therapy applications.

Enhanced Transfection Efficiency And Targeted Delivery Of Self-Assembling H-R3-Dendriplexes In Egfr-Overexpressing Tumor Cells

EGF-coated Nano-Dendriplexes for Tumor-Targeted Nucleic Acid Deliveryin Vivo

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers.

Multifunctional Amphiphilic Peptide Dendrimer As Nonviral Gene Vectors for Effective Cancer Therapy Via Combined Gene/photodynamic Therapies

Epidermal Growth Factor-Peg Functionalized Pamam-Pentaethylenehexamine Dendron for Targeted Gene Delivery Produced by Click Chemistry

Construction of a Star-Shaped Copolymer As a Vector for FGF Receptor-Mediated Gene Delivery in Vitro and in Vivo.

Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.

Red fluorescent AIEgens based multifunctional nonviral gene vectors for the efficient combination of gene therapy and photodynamic therapy in anti-cancer

Dendrimer-triglycine-EGF Nanoparticles for Tumor Imaging and Targeted Nucleic Acid and Drug Delivery

FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine.

Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy.

Facile Formation of PAMAM Dendrimer Nanoclusters for Enhanced Gene Delivery and Cancer Gene Therapy

Enhancing Tumor-Specific Intracellular Delivering Efficiency of Cell-Penetrating Peptide by Fusion with a Peptide Targeting to EGFR

PEI functionalized cell membrane for tumor targeted and glutathione responsive gene delivery

A Novel Disulfide Bond-Mediated Cleavable RGD-modified PAMAM Nanocomplex Containing Nuclear Localization Signal HMGB1 for Enhancing Gene Transfection Efficiency

A Dual-Targeting Drug Co-Delivery System for Tumor Chemo- and Gene Combined Therapy.

Harnessing the Peg-Cleavable Strategy to Balance Cytotoxicity, Intracellular Release and the Therapeutic Effect of Dendrigraft Poly-L-Lysine for Cancer Gene Therapy

Arginine-rich Peptide Based Nanoparticles with Bridge-Like Structure: Enhanced Cell Penetration and Tumor Therapy Effect

FGF Receptor-Mediated Gene Delivery Using Ligands Coupled to PEI-β-CyD

Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy